Explore 3 Stock Ideas & Industry Insights Download Free Report

News

MBX Biosciences CEO Hoerter Sells 4,893 Shares for Tax Cover

Steven L. Hoerter, Chairman, President and CEO of MBX Biosciences, Inc., filed a Form 4 on November 12, 2026, reporting the sale of 4,893 shares of common stock on November 10, 2026, to cover tax obligations arising from the vesting of restricted stock units.

Vinay Lochav | 12 November 2026

Valens Semiconductor VP Finance Rozenberg Sells 625 Shares at $1.5

Haine Yael Rozenberg, VP Finance of Valens Semiconductor Ltd., filed a Form 4 on November 12, 2026, reporting the sale of 625 ordinary shares on November 9, 2026, pursuant to a Rule 10b5-1 trading plan.

Shwetambri Chauhan | 12 November 2026

AIM ImmunoTech CEO Equels Buys 39,000 Shares at $0.138

Thomas K. Equels, CEO and President of AIM ImmunoTech Inc., filed a Form 4 on November 12, 2026, disclosing an open-market purchase of 39,000 shares of common stock on November 10, 2026.

Shwetambri Chauhan | 12 November 2026

Seth Lederman Buys 5,000 Tonix Shares at $4.055

Seth Lederman, Chief Executive Officer and Director of Tonix Pharmaceuticals Holding Corp., filed a Form 4 on November 12, 2026, reporting the open-market purchase of 5,000 shares of common stock on November 11, 2026.

Aakashdeep | 12 November 2026

Todd Hornbeck Buys 280,865 HOS Shares on Nov 10-11

Todd M. Hornbeck, President and CEO of Hornbeck Offshore Services, Inc., filed a Form 4 on November 11, 2026, disclosing two open-market purchases of Hornbeck Offshore Services common stock totaling 280,865.849 shares made on November 10 and November 11, 2026.

Vinay Lochav | 12 November 2026

Trustmark Bank Merger Agreement With Hancock Whitney Disclosed

Trustmark Corporation, the Jackson, Mississippi-based parent of Trustmark Bank, filed an 8-K on November 12, 2026, disclosing the execution of a merger agreement under which Trustmark will merge with and into Hancock Whitney Corporation, with Hancock Whitney continuing as the surviving corporation.

Shwetambri Chauhan | 12 November 2026

Chernett Buys 1,391 STLN Call Options, Flags Short-Swing Profit

Director Jorey Chernett filed a Form 4 with the SEC on November 12, 2026, disclosing a purchase of call options in Starling Oncology, Inc. (NASDAQ:STLN) on November 11, 2026, and separately noting a calculated short-swing profit the reporting person intends to disgorge to the …

Manish Choudhary | 12 November 2026

Scheiwer Acquires 3.202 Scotts Miracle-Gro Shares via Code J

Mark J. Scheiwer, Executive Vice President, CFO and CAO of Scotts Miracle-Gro Co, filed a Form 4 on November 12, 2026, reporting a transaction in common shares dated October 30, 2026.

Aakashdeep | 12 November 2026

Exagen Director Chernett Buys 71,315 Shares, Flags Short-Swing Profit

Exagen Inc. director Jorey Chernett filed a Form 4 on November 12, 2026, disclosing the purchase of 71,315 shares of common stock on November 11, 2026, and noting an intent to disgorge a calculated short-swing profit to the issuer.

Anjali Anand | 12 November 2026

Director David Evans Sells 2,655 SMG Shares at $66.42

Director David C. Evans of Scotts Miracle-Gro Co filed a Form 4 on November 12, 2026, disclosing a sale of common shares on November 9, 2026.

Nitish Kishor | 12 November 2026
Support

Hi! How can we help you today?

Loading…